Symbol: |
EVC
|
Description: |
Ellis van Creveld syndrome [Source:HGNC Symbol;Acc:3497]
|
Location: |
Chr4:5712924-5830772[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:163
Gene |
Compound |
Gen_sig |
Exp_pattern |
EVC |
Camptothecin hemisuccinate sodium salt |
0.034 |
Down |
EVC |
Camptothecin lysinate HCl |
0.048 |
Down |
EVC |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.023 |
Down |
EVC |
NSC 611074 |
0.016 |
Down |
EVC |
NSC 611274 |
0.037 |
Up |
EVC |
NSC 62349 |
0.014 |
Down |
EVC |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.049 |
Down |
EVC |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.018 |
Down |
EVC |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.022 |
Down |
EVC |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.007 |
Up |
EVC |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.013 |
Down |
EVC |
VIRIDENOMYCIN |
0.007 |
Down |
EVC |
NSC 651668 |
0.017 |
Down |
EVC |
NSC 656471 |
0.035 |
Up |
EVC |
NSC 658089 |
0.003 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:118
Total:8 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:4
Gene |
Gen_transcript |
miRNA |
miR_location |
EVC |
ENST00000264956 |
hsa-mir-425-5p |
Chr3:49057632-49057654[-] |
EVC |
ENST00000382674 |
hsa-mir-425-5p |
Chr3:49057632-49057654[-] |
EVC |
ENST00000382674 |
hsa-mir-541-5p |
Chr14:101530841-101530865[+] |
EVC |
ENST00000382674 |
hsa-mir-614 |
Chr12:13068816-13068838[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|